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Introduction 
Head-out water immersion (WI) increases 
central venous and atrial volume by shifting 
blood from peripheral vessels to the intra-
thoracic venous bed. Because of stimulation 
of central low pressure and volume recep-
toprs there is an influence in hemodynamic 
and renal regulations. Thus thermoneutral 
W I results in a progressive diuresis, nat-
riuresis and kaliuresis; concerning hor-
monal reactions W I leads to a decrease of 
antidiuretic hormone ( A D H ) , renin and al-
dosterone in the blood (for Rev. see [4]). 
Furthermore it could be demonstrated in a 
previous study, that W I stimulates atrial 
natriuretic factor (ANF) in man [5] and thus 
seems to be a useful mean to study the phys-
iological role of A N F in acute volume regu-
lation. 
In pregnancy there are changes in the 
control of extracellular water and electro-
lyte homeostasis and therefore it may be of 
interest to look at the responses of healthy 
pregnant women and patients with EPH-
gestosis in a standardized water bath, re-
garding renal functions, plasma volume, 
renin, aldosterone and especially the atrial 
natriuretic factor. 
Methods 
Experiments were done with 27 women 
(group I [n = 13]: no pathological 
symptoms; group I I [n = 14]: EPH-gestosis) 
after obtaining their informed consent. A t 
the time of the studies the women were pre-
gnant between the 28 t h and the 38 t h week. 
Furthermore a group (n = 9) of healthy non-
pregnant women were investigated con-
cerning ANF. The subjects were on an ordi-
nary diet; alcohol, tobacco, tea and coffee 
were forbidden at the day of the experi-
ment. The procedure consisted of a 40 min 
control period, followed by a 40 min bath 
(35°C) and a 40 min recovery period. Blood 
samples drawn from a brachial vein by 
means of a butterfly needle were analysed 
for A N F (radio-immuno-assay with X A D -
extracted plasma [1]), plasma renin activity 
(PRA) and aldosterone (commercial kits). 
Urine samples were collected after every 
period for determinations of urine output, 
sodium and potassium (flame photometry), 
creatinine (Jaffe reaction) and osmolality 
(freezing point depression). Changes of the 
hematocrit allowed the calculation of 
changes in the plasma volume. If necessary 
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patients received medication. Data are 
given as means and standard errors of the 
mean. 
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only in the gestosis group. During W I rises 
of plasma volume of about 8 or 9% could be 
demonstrated. 
Results 
As can be seen in Fig. 1, W I significantly in-
creased ANF plasma levels in all three 
groups. After 40 minutes there was an in-
crease of about 50-70%. In the recovery 
period the hormone decreased with ten-
dency to baseline levels. Neither basal nor 
stimulated values showed statistical differ-
ences between the groups. Only three pre-
gnant women didn't respond. 
W I was followed by a significant decrease 
in PR A and aldosterone. The drop in 
plasma levels was similar in the groups. No 
relationship between these hormonal 
changes and ANF could be found. 
There were distinct effects of W I con-
cerning renal excretion. Urinary flow rate 
was enhanced to 3 or 4 times of controls. 
Mean values of sodium and potassium ex-
cretion were increased, too. The gestosis-
group showed lower basal values for sodium 
and significantly higher excretion rates after 
W I compared to the healthy pregnant 
women. Correspondingly there was an in-
crease in fractionated excretions. In all 
groups W I resulted in increased osmotic 
and free water clearance. Creatinine clear-
ance reached significantly higher values 
Discussion 
A striking change in hemodynamics occurs 
in women during pregnancy and some 
900 mmol sodium progressively accumu-
lates and total body water increases by 6 to 8 
liters, distributed amongst the fetus, the 
placenta and enlarged maternal blood and 
interstitial fluid volumes. Abnormalities of 
sodium and water balance are thought to be 
connected with diseases such as pre-eclamp-
sia. On the other side pregnancies compli-
cated by pre-eclampsia are associated with a 
reduction of plasma volume and central 
venous pressure. Furthermore the renin-al-
dosterone axis is involved in circulatory reg-
ulation and water and electrolyte balance. 
Some authors demonstrated an elevation 
of plasma ANF levels during normal pre-
gnancy and much higher levels in patients 
suffering from EPH-gestosis [2, 7, 8, 10]. 
Higher A N F levels in normal pregnancy 
were thought to be a consequence of the in-
creased blood volume. Other results 
suggest that plasma A N F levels are normal 
in women during uncomplicated pregnancy 
[6, 3]. In our studies the basal values didn't 
show any significant differences between 
the groups. 
ANF 
[fmol/ml] 
15n 
10-
5-
0 J 
pregnant women 
EPH-gestosis 
pregnant women 
healthy 
=lmm e r s i onl 
20 40 60 
t [min] 
Fig. 1. Behaviour of plasma ANF during 
and after thermoneutral water immersion 
in healthy pregnant women, patients with 
EPH-gestosis and non-pregnant controls 
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There is the question if the trigger mecha-
nisms of ANF secretion are less sensitive to 
central blood volume changes in pregnancy 
and uncomplicated pregnancy. Results 
from investigations with the W I model pub-
lished Doniec-Ulman et al. [3] are consis-
tent with this hypothesis. They documented 
a less stimulation rate for ANF in healthy 
pregnant women and women with moderate 
EPH-gestosis as compared to non-pregnant 
controls. Contrary to this we found compar-
able values of stimulated A N F during W I in 
all groups. We didn't observe any changes in 
the slope of the ANF-increases. That might 
not indicate a desensitisation of ANF secre-
tion. Also an intact ANF-system seems to 
be necessary to normalize the water and 
electrolyte balance in the postnatal period 
[9]. However, statements about the Wl-in-
duced maximum concentrations of ANF 
cannot be given by our studies. Renin and 
aldosterone showed the decrease which is 
known in immersion physiology. 
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